<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 3.3c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: C:\Users\EricStop\Documents\Edgar\Myskin\10Q 120331\XBRL\XBRL120331.xfr; Date: 2012/11/06T06:41:55 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2011-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2011-01-31" xmlns:us-roles="http://fasb.org/us-roles/2011-01-31" xmlns:us-types="http://fasb.org/us-types/2011-01-31" xmlns:myskin="http://myskin/20120331">
    <link:schemaRef xlink:href="myskin-20120331.xsd" xlink:type="simple" />
    <xbrli:context id="From2012-01-01to2011-12-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001436161</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2012-01-01</xbrli:startDate>
        <xbrli:endDate>2012-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-11-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001436161</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-11-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-12-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001436161</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2012-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001436161</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2011-01-01to2011-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001436161</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2011-01-01</xbrli:startDate>
        <xbrli:endDate>2011-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2011-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001436161</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2011-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2010-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001436161</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2010-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2012-01-01to2011-12-30">MySkin, Inc.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2012-01-01to2011-12-30">0001436161</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2012-01-01to2011-12-30">10-Q</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2012-01-01to2011-12-30">2012-03-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2012-01-01to2011-12-30">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2012-01-01to2011-12-30">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2012-01-01to2011-12-30">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2012-01-01to2011-12-30">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2012-01-01to2011-12-30">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2012-01-01to2011-12-30">Smaller Reporting Company</dei:EntityFilerCategory>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2011-11-15" unitRef="Shares" decimals="INF">1505000</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentFiscalPeriodFocus contextRef="From2012-01-01to2011-12-30">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2012-01-01to2011-12-30">2012</dei:DocumentFiscalYearFocus>
    <dei:EntityPublicFloat contextRef="AsOf2011-11-15" unitRef="USD" decimals="0">420000</dei:EntityPublicFloat>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2011-12-30" unitRef="USD" decimals="0">10501</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">56294</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2011-03-31" unitRef="USD" decimals="0">6764</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2010-12-31" unitRef="USD" decimals="0">3608</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AssetsCurrent contextRef="AsOf2011-12-30" unitRef="USD" decimals="0">16160</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">64098</us-gaap:AssetsCurrent>
    <us-gaap:FixturesAndEquipmentGross contextRef="AsOf2011-12-30" unitRef="USD" decimals="0">33387</us-gaap:FixturesAndEquipmentGross>
    <us-gaap:FixturesAndEquipmentGross contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">39043</us-gaap:FixturesAndEquipmentGross>
    <us-gaap:Assets contextRef="AsOf2011-12-30" unitRef="USD" decimals="0">49547</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">103141</us-gaap:Assets>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="AsOf2011-12-30" unitRef="USD" decimals="0">0</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">50000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2011-12-30" unitRef="USD" decimals="0">28074</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">76640</us-gaap:LiabilitiesCurrent>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2011-12-30" unitRef="USD" decimals="0">147075</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">147075</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2011-12-30" unitRef="USD" decimals="0">-127022</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">-121994</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="AsOf2011-12-30" unitRef="USD" decimals="0">21473</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">26501</us-gaap:StockholdersEquity>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2011-12-30" unitRef="USD" decimals="0">22649</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">26640</us-gaap:AccountsPayableCurrent>
    <us-gaap:CommonStockValue contextRef="AsOf2011-12-30" unitRef="USD" decimals="0">1420</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">1420</us-gaap:CommonStockValue>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2011-12-30" unitRef="USD" decimals="0">49547</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">103141</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2011-12-31" unitRef="Shares" decimals="INF">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2011-12-30" unitRef="Shares" decimals="INF">1420000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2011-12-31" unitRef="Shares" decimals="INF">1420000</us-gaap:CommonStockSharesIssued>
    <us-gaap:SalesRevenueNet contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">25838</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">14506</us-gaap:SalesRevenueNet>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">19881</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">10099</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">5957</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">4407</us-gaap:GrossProfit>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">10986</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">14425</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">10986</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">14425</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">-5029</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">-10018</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">0</us-gaap:InterestExpense>
    <us-gaap:OtherExpenses contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">0</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">0</us-gaap:OtherExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">-5029</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">-10018</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">-5029</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">-10018</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2012-01-01to2011-12-30" unitRef="USDPShares" decimals="INF">-0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2011-01-01to2011-03-31" unitRef="USDPShares" decimals="INF">-.01</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:Depreciation contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">5656</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">5140</us-gaap:Depreciation>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">-3990</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">15208</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">4207</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">8300</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">0</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">-5144</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">5144</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">-50000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">0</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">-45793</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">3156</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <myskin:WeightedAverageSharesOutstandingBasicAndDiluted contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">1420000</myskin:WeightedAverageSharesOutstandingBasicAndDiluted>
    <myskin:WeightedAverageSharesOutstandingBasicAndDiluted contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">1420000</myskin:WeightedAverageSharesOutstandingBasicAndDiluted>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2012-01-01to2011-12-30">&lt;p style="margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING&#13;POLICIES&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Current Operations and Background&lt;/i&gt;&lt;/b&gt;&#13;&amp;#151; MySkin, Inc. (&amp;#147;MySkin&amp;#148; or the &amp;#147;Company&amp;#148;), a California corporation, was incorporated on November&#13;15, 2007. We ceased to be a development stage enterprise effective January 1, 2008 as our planned principal operations had commenced.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;MySkin currently&#13;offers management services to one medspa which provides skin resurfacing, skin rejuvenation, vein treatment, microdermabrasion,&#13;hair reduction, chemical peels and other age-management services. Our management services include, but are not limited to, marketing,&#13;providing working capital for inventory and accounts receivable, facilities, equipment, administration, personnel and management&#13;expertise for medspas. Utilizing electronic medical records, vendor relationships and customer service protocols, we intend to&#13;brand and replicate our management services with other doctors and practitioners in demographically selected metropolitan areas.&#13;We currently lease the facility for our center and complete improvements in the facility that houses the medspa business. We will&#13;own all of the equipment utilized in the medspa, and we provide all of the administrative and sales support on all non-medically&#13;related areas. At this location MTA performs the advanced skin care professional services.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On March 1, 2009,&#13;we entered into a Facilities and Management Services Agreement with Maria Teresa Agner, MD, Inc. (&amp;#147;MTA&amp;#148;) a California&#13;profession corporation pursuant to which we granted MTA the rights to perform advanced skin services in our current center. MTA&#13;is a related party as Marichelle Stoppenhagen, our president and principle shareholder, owns 49% of MTA. As a result, MTA is responsible&#13;for hiring all physicians and nurse practitioners who operate in the medspa. Under this agreement, we pay all costs and expenses&#13;reasonably related to the provision of our services, including but not limited to office rent, utilities and other occupancy costs,&#13;compensation benefits and employment costs associated with all non-licensed personnel, general liability insurance, equipment lease&#13;and maintenance costs, advertising and promotion, support personnel and contracted consultants, office supplies, and all such other&#13;direct and indirect expenses reasonably incurred by Company, with respect to the provision of the Management Services for the Practice&#13;(collectively, &amp;#34;Management Expenses&amp;#34;). Under this agreement, MTA is obligated to reimburse Management Expenses and pay&#13;a monthly service fee equal to forty percent (40%) of gross collected revenue with a minimum amount of $2,500 per month (&amp;#147;Service&#13;Fee&amp;#148;). Gross Collected Revenue shall be defined as the gross amount of all sums collected from the professional services&#13;performed and medical supplies provided by or on behalf of doctor in the practice, and shall not include revenue collected by Company&#13;from customers of Company for non-medical services or products provided. MTA has retained the services of Ms. Stoppenhagen, our&#13;president, Maria Teresa Agner, MD to provide services at our facility.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Given sufficient&#13;capital, we plan to expand our management services for other locations through partnering with physicians to manage new medspas,&#13;failed medspas, and by managing new store locations near young retirement communities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Going Concern&lt;/i&gt;&lt;/b&gt;&#13;&amp;#151; The accompanying financial statements have been prepared assuming the Company will continue as a going concern. The Company&#13;has suffered losses from operations since its inception and has an accumulated deficit of $127,022 and a stockholder&amp;#146;s equity&#13;of $21,473 at March 31, 2012. The financial statements do not include any adjustments relating to the recoverability and classification&#13;of recorded asset amounts or amounts and classifications of liabilities that might be necessary should the Company be unable to&#13;continue its existence. The recovery of the Company&amp;#146;s assets is dependent upon continued operations of the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In addition, the&#13;recovery of the Company&amp;#146;s assets is dependent upon future events, the outcome of which is undetermined. The Company intends&#13;to continue to attempts to raise additional capital, but there can be no certainty that such efforts will be successful.&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: justify; text-indent: 0.5in"&gt;&lt;i&gt;Consolidation&#13;Policy&lt;/i&gt; The Company has only one contractual relationship with MTA which is the management services agreement. The Company evaluated&#13;the various relationships between the parties to determine whether to consolidate MTA as a variable interest entity pursuant to&#13;ASC 810, &lt;i&gt;Consolidation&lt;/i&gt; . The Company determined that it was not the primary beneficiary of the interest and that it should&#13;not consolidate MTA. The Company&amp;#146;s conclusion was based upon an analysis of the various relationships and California state&#13;law restrictions on relationships between licensed professionals and businesses. To complete its analysis, management made assumptions&#13;regarding the relevance of certain factors, including state law requirements, which were given significant weight. In the event&#13;that state law should change, there should be material changes in the relationships or management&amp;#146;s judgment as to the relevance&#13;of various factors should change, the Company might determine that consolidation would be appropriate.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/b&gt;&#13;&amp;#151; The accompanying unaudited financial statements are presented in accordance with the requirements for Form 10-Q and Regulation&#13;S-X. In the opinion of management, all adjustments (all of which were of a normal recurring nature) considered necessary to fairly&#13;present the financial position, results of operations, and cash flows of the Company on a consistent basis, have been made.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;These results have&#13;been determined on the basis of generally accepted accounting principles and practices applied consistently with those used in&#13;the preparation of the Company's financial statements. Operating results for the three months ended March 31, 2012 are not necessarily&#13;indicative of the results that may be expected for the year ending December 31, 2012.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company recommends&#13;that the accompanying unaudited financial statements for the interim period be read in conjunction with the Company's financial&#13;statements for the year ended December 31, 2011 included in the Company's Annual Report on Form 10-12G/A.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying&#13;unaudited financial statements have been prepared in conformity with accounting principles generally accepted in the United States&#13;of America.&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/b&gt;&#13;&amp;#151;The preparation of financial statements in conformity with generally accepted accounting principles in the United States&#13;of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and&#13;disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and&#13;expenses during the reporting period. Actual results could differ from those estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Cash and Cash&#13;Equivalents&lt;/i&gt;&lt;/b&gt; &amp;#151; The Company considers investments with original maturities of 90 days or less to be cash equivalents.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Accounts Receivable&#13;-&lt;/i&gt;&lt;/b&gt; The Company extends credit to its customers. Collateral is generally not required. Credit losses are provided for in&#13;the financial statements based on management&amp;#146;s evaluation of historical and current industry trends. Although the Company&#13;expects to fully collect amounts due, actual collections may differ from estimated amounts. The Company estimates an allowance&#13;for doubtful accounts based upon a percentage of revenue earned. When the Company expects that there is less than a 10% chance&#13;of collection, the Company writes the receivable off to its allowance for doubtful accounts. The Company does not typically accrue&#13;interest or fees on past due amounts.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Inventory&lt;/i&gt;&lt;/b&gt;&#13;- Inventory is valued at the lower of cost or market. Cost is determined using standard costs, which approximates the first-in,&#13;first-out method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Equipment&lt;/i&gt;&lt;/b&gt;&#13;&amp;#151; Equipment are stated at cost and are depreciated using the straight-line method over their estimated useful lives, ranging&#13;from three to five years.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Revenue Recognition&lt;/i&gt;&lt;/b&gt;&#13;&amp;#151; The Company&amp;#146;s revenues are derived from management services provided to MTA, a related party. The Company provides&#13;nonmedical services and facilities based on contractual prices established in advance that extend continuously over a set time&#13;for a fixed percentage of the contracting physician&amp;#146;s gross revenues (as defined in the Management Services Agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: justify"&gt;The Company recognizes revenue&#13;when the following criteria of revenue recognition are met: (1) persuasive evidence that an arrangement exists; (2) delivery has&#13;occurred or services rendered; (3) the fee is fixed or determinable; and (4) collectability is reasonably assured.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;According to ASC 605-45-45, the revenue&#13;is reported as gross revenue because the Company is the primary obligor, sets the sales price and bears the risk of collection&#13;from the customers.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Our revenues our presented as the total&#13;sales of services performed and the total products sold at the facility of products sold.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Our cost&#13;of goods sold equals the cost of services and products sold which is equal to MTA&amp;#146;s portion of the gross profit and the cost&#13;of services, materials used in those services and products sold. The gross profit equals the Company&amp;#146;s management fee.&lt;/font&gt;&lt;font style="font-size: 12pt"&gt;&#13;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Advertising&#13;Costs ---&lt;/i&gt;&lt;/b&gt; Advertising costs have primarily consisted of advertising materials and costs of trade shows the Company has&#13;attended. All advertising costs have been expensed as incurred.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Shipping and&#13;Handling Costs&lt;/i&gt;&lt;/b&gt; &amp;#151; The Company records revenue related to shipping and handling costs charged to customers in revenues.&#13;The related expense is recorded in cost of sales in the accompanying statements of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/b&gt;&#13;&amp;#151; Income taxes are recorded using the asset and liability method. Under the asset and liability method, tax assets and liabilities&#13;are recognized for the tax consequences attributable to differences between financial statement carrying amounts of existing assets&#13;and liabilities and their respective tax bases. Future tax assets and liabilities are measured using the enacted tax rates expected&#13;to apply when the asset is realized or the liability settled. The effect on future tax assets and liabilities of a change in tax&#13;rates is recognized in income in the period that enactment occurs. To the extent that the Company does not consider it more likely&#13;than not that a future tax asset will be recovered, it provides a valuation allowance against the excess.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company follows&#13;the provisions of ASC 740 Income taxes (ASC 740). As a result of the ASC 740, the Company makes a comprehensive review of its portfolio&#13;of tax positions in accordance with recognition standards established by ASC 740. As a result of the implementation, the Company&#13;recognized no material adjustments to liabilities or stockholders equity. When tax returns are filed, it is highly certain that&#13;some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about&#13;the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position&#13;is recognized in the financial statements in the period during which, based on all available evidence, management believes it is&#13;more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes,&#13;if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not&#13;recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon&#13;settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the&#13;amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheets&#13;along with any associated interest and penalties that would be payable to the taxing authorities upon examination.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Interest associated&#13;with unrecognized tax benefits are classified as interest expense and penalties are classified in selling, general and administrative&#13;expenses in the statements of income. The adoption of FIN 48 did not have a material impact on the Company&amp;#146;s financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Net Loss Per&#13;Share&lt;/i&gt;&lt;/b&gt; &amp;#151; The Company computes net loss per share in accordance with ASC 260 Earnings per Share (ASC 260). Under the&#13;provisions of ASC 260 , basic net loss per share includes no dilution and is computed by dividing the net loss available to common&#13;stockholders for the period by the weighted average number of shares of common stock outstanding during the period. The dilution&#13;loss per share takes into consideration shares of common stock outstanding (computed under basic net loss per share) and potentially&#13;dilutive shares of common stock that are not anti-dilutive.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Concentration&#13;of Credit Risk&lt;/i&gt;&lt;/b&gt; &amp;#151; Financial instruments that potentially subject the Company to credit risk consist of cash and accounts&#13;receivable. The Company maintains its cash with high credit quality financial institutions; at times, such balances with any one&#13;financial institution are not insured by the FDIC. Concentration of credit risk associated with accounts receivable is significant&#13;due to the limited number of customers. The Company performs ongoing credit evaluations of its customers and generally requires&#13;partial deposits.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Financial&#13;Instruments&lt;/i&gt;&lt;/b&gt; &amp;#151;The Company&amp;#146;s financial instruments consist of cash, accounts receivable, accounts payable and&#13;accrued expenses. The carrying values of cash, accounts receivable and accounts payable are representative of their fair values&#13;due to their short-term maturities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Recently&#13;Issued Accounting Pronouncements&lt;/i&gt;&lt;/b&gt; &amp;#151; With the exception of those listed below, there have been no recent accounting&#13;pronouncements or changes in accounting pronouncements that are of material significance, or have potential material significance,&#13;on our financial position, results of operations or cash flows.&lt;/font&gt;&lt;font style="font-size: 12pt"&gt; &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: justify; text-indent: 0.5in"&gt;In May 2011,&#13;the FASB issued Accounting Standards Update No. 2011-04, &amp;#147;Fair Value Measurement (Topic 820): Amendments to Achieve Common&#13;Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs&amp;#148;. The amendments result in common fair value measurement&#13;and disclosure requirements in U.S. generally accepted accounting principles (GAAP) and International Financial Reporting Standards&#13;(IFRSs), and do not require additional fair value measurements and are not intended to establish valuation standards or affect&#13;valuation practices. The amendments in this update are effective during interim and annual periods beginning after December 15,&#13;2011. Adoption of the new requirement is not expected to have an effect on the Company&amp;#146;s financial position, results of operations&#13;or cash flow.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2012-01-01to2011-12-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 6 &amp;#150; RELATED PARTY NOTE&#13;PAYABLE&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In December 2011,&#13;we entered into a Revolving Promissory Note (the &amp;#147;Note&amp;#148;) with Marichelle Stoppenhagen, our president. Under the terms&#13;of the Note, Marichelle Stoppenhagen agreed to advance us, from time to time and at the request of the Company, amounts up to an&#13;aggregate of $100,000 until December 31, 2012. All advances shall be paid on or before December 31, 2012 and interest shall accrue&#13;from the date of any advances on any principal amount withdrawn, and on accrued and unpaid interest thereon, at the rate of six&#13;percent (6%) per annum, compounded annually. As of March 31, 2012, there was zero owed under the note.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2011-12-30" unitRef="USD" decimals="0">5425</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">0</us-gaap:AccountsPayableRelatedPartiesCurrent>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent contextRef="AsOf2011-12-30" unitRef="USD" decimals="0">0</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">716</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2011-12-30" unitRef="USD" decimals="0">5659</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2011-12-31" unitRef="USD" decimals="0">7088</us-gaap:InventoryNet>
    <us-gaap:IncreaseDecreaseInReceivables contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">0</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">238</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">6141</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">-890</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">1429</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">-1378</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">0</us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties>
    <us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">0</us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties>
    <us-gaap:IncomeTaxesPaid contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">0</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">1658</us-gaap:IncomeTaxesPaid>
    <us-gaap:InterestPaid contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">0</us-gaap:InterestPaid>
    <us-gaap:InterestPaid contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">0</us-gaap:InterestPaid>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2012-01-01to2011-12-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 2 - CONCENTRATION OF CREDIT&#13;RISK&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Although we are&#13;directly affected by the economic well being of significant customers, we do not believe that significant credit risk exists at&#13;March 31, 2012 and December 31, 2011. We perform ongoing evaluations of our customers.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company maintains&#13;its cash balances in one financial institution that does not exceed amounts insured by the Federal Deposit Insurance Corporation&#13;up to $250,000, per financial institution. As of March 31, 2012 and December 31, 2011, the Company had no deposits that exceeded&#13;federally-insured amounts. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant&#13;credit risk on cash.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2012-01-01to2011-12-30">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 3 &amp;#150; EQUIPMENT&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 12pt/0.05pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;Equipment, consists of the following at:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 11pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;March 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;December 31,&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;2012&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;2011&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 56%"&gt;Equipment&lt;/td&gt;&lt;td style="width: 8%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;109,705&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;109,705&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Less accumulated depreciation and amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(76,318&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(70,662&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;33,387&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;39,043&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2012-01-01to2011-12-30" unitRef="USD" decimals="0">-50000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2011-01-01to2011-03-31" unitRef="USD" decimals="0">0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2011-12-31" unitRef="Shares" decimals="INF">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2011-12-30" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2011-12-31" unitRef="Shares" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
</xbrli:xbrl>
